Distal lower extremity sarcomas: frequency of occurrence and patient survival rate.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 15134614)

Published in Foot Ankle Int on May 01, 2004

Authors

Trisha Zeytoonjian1, Henry J Mankin, Mark C Gebhardt, Francis J Hornicek

Author Affiliations

1: Orthopaedic Oncology Service, Massachusetts General Hospital, Boston 02114, USA.

Associated clinical trials:

Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle | NCT03129672

Articles citing this

Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res (2008) 1.11

Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours. Sarcoma (2009) 1.10

Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res (2012) 0.95

Treatment of primary malignant bone tumours of the distal tibia. Int Orthop (2005) 0.88

Do malignant bone tumors of the foot have a different biological behavior than sarcomas at other skeletal sites? Sarcoma (2013) 0.83

Trauma as pathogenesis of a plantar forefoot fibrolipoma: first case and review of the literature. Case Rep Surg (2013) 0.79

The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas. World J Surg Oncol (2013) 0.77

Recent developments in the surgical treatment of bone tumors and their impact on quality of life. Sarcoma (2013) 0.75

Clinical management and surgical treatment of distal fibular tumours: a case series and review of the literature. Int Orthop (2012) 0.75

The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma. World J Surg Oncol (2011) 0.75

Foot sarcomas: Factors affecting oncological and functional outcomes. Oncol Lett (2011) 0.75

Malignant tumours of the foot and ankle. EFORT Open Rev (2017) 0.75

Vascularized fibular medialization for reconstruction of the tibial defects following tumour excision. Int Orthop (2017) 0.75

Primary Osteosarcoma of the Distal Fibula treated with Distal Fibulectomy with a Five-Year Follow-up: A Case Report. Malays Orthop J (2017) 0.75

Reconstruction of the distal tibia following resection of aggressive bone tumours using a custom-made megaprosthesis. J Orthop (2017) 0.75

Articles by these authors

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med (2003) 8.48

Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol (2005) 4.10

A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96

Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology (2003) 3.86

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol (2008) 3.34

Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am (2011) 3.23

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol (2003) 3.21

Fairness to all: gender and sex in scientific reporting. Clin Orthop Relat Res (2013) 2.98

Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A (2012) 2.66

Editorial: Words hurt--avoiding dehumanizing language in orthopaedic research and practice. Clin Orthop Relat Res (2014) 2.46

Articular cartilage and osteoarthritis. Instr Course Lect (2005) 2.39

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys (2003) 2.36

Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol (2007) 2.25

Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control (2005) 1.99

USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol (2004) 1.82

Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res (2004) 1.80

Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am (2002) 1.80

Infection in massive bone allografts. Clin Orthop Relat Res (2005) 1.73

Giant cell tumor of bone. J Am Acad Orthop Surg (2013) 1.59

Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res (2004) 1.56

Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol (2012) 1.51

Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res (2004) 1.50

Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys (2006) 1.50

Allografts about the Knee in Young Patients with High-Grade Sarcoma. Clin Orthop Relat Res (2004) 1.45

Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg (2012) 1.45

Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma. Cancer (2014) 1.43

Survival data for patients with malignant schwannoma. Clin Orthop Relat Res (2004) 1.43

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.43

Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys (2007) 1.42

Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One (2009) 1.40

Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg (2002) 1.39

MicroRNA Involvement in Osteosarcoma. Sarcoma (2012) 1.38

Giant-cell tumor of the distal forearm. J Hand Surg Am (2004) 1.38

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol (2004) 1.37

Predicting fracture through benign skeletal lesions with quantitative computed tomography. J Bone Joint Surg Am (2006) 1.37

Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol (2002) 1.37

Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol (2006) 1.31

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys (2008) 1.27

Unicameral bone cyst: a retrospective study of three surgical treatments. Clin Orthop Relat Res (2008) 1.27

Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One (2011) 1.24

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol (2008) 1.23

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol (2002) 1.22

Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene (2005) 1.21

Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol (2010) 1.19

Long-term followup of proximal femoral allografts. Clin Orthop Relat Res (2002) 1.19

Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res (2003) 1.18

Bone cancer. J Natl Compr Canc Netw (2013) 1.17

Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol (2014) 1.17

Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res (2010) 1.16

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One (2010) 1.16

Clear cell sarcoma of soft tissues. J Surg Oncol (2007) 1.15

Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res (2004) 1.15

Internal hemipelvectomy for the management of pelvic sarcomas. Surg Oncol Clin N Am (2005) 1.15

Total femur replacement procedures in tumor treatment. Clin Orthop Relat Res (2005) 1.14

Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg (2003) 1.14

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol (2005) 1.13

Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol (2007) 1.13

Treatment of giant cell tumors with allograft transplants: a 30-year study. Clin Orthop Relat Res (2005) 1.11

Management of acral myxoinflammatory fibroblastic sarcoma. Cancer (2010) 1.09

Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. Am J Surg Pathol (2013) 1.08

A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther (2009) 1.07

Surgical treatment of hemangiomas of soft tissue. Clin Orthop Relat Res (2002) 1.07

Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review. Clin Orthop Relat Res (2014) 1.06

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. BMC Cancer (2009) 1.05

Malignant lymphoma of bone: a review of 119 patients. Clin Orthop Relat Res (2013) 1.05

Soft tissue sarcoma resection volume associated with wound-healing complications. Clin Orthop Relat Res (2007) 1.05

ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res (2011) 1.04

Paget's sarcoma: a historical and outcome review. Clin Orthop Relat Res (2005) 1.04

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Mol Cancer Ther (2009) 1.04

Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol (2003) 1.03

Malignant tumors of the pelvis: an outcome study. Clin Orthop Relat Res (2004) 1.03

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J Orthop Res (2010) 1.03

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2010) 1.02

Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells. Cancer Chemother Pharmacol (2010) 1.01